Related Experiment Video

Updated: Jun 21, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs

H A Burris1

  • 1Sarah Cannon Research Institute, Nashville, TN 37203, USA. howard.burris@scresearch.net

Oncogene
|August 15, 2009
PubMed

Insights

Non-small-cell lung cancer (NSCLC) treatments show limited efficacy and significant toxicity. New agents are in development to improve outcomes for advanced NSCLC patients.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Non-small-cell lung cancer (NSCLC) is a leading cause of cancer mortality globally.
  • Current treatments, including chemotherapy and targeted therapies, offer modest survival benefits and significant patient toxicity.
  • Acquired resistance limits the long-term effectiveness of targeted agents in NSCLC.

Purpose of the Study:

  • To review the limitations of current NSCLC therapies.
  • To discuss novel therapeutic agents in clinical development for advanced NSCLC.

Main Methods:

  • Literature review of current NSCLC treatment modalities.
  • Analysis of emerging therapeutic agents for advanced NSCLC.

Main Results:

  • Current standard treatments for NSCLC have significant limitations in efficacy and safety.
  • Several novel agents are under investigation, potentially offering improved therapeutic profiles.

Conclusions:

  • There is a critical need for novel therapeutic strategies in advanced NSCLC.
  • Emerging agents in clinical development hold promise for improving patient outcomes.

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.